Basic Information
| LncRNA/CircRNA Name | LINC00160 |
| Synonyms | NA |
| Region | GRCh38_21:34723807-34737181 |
| Ensemble | ENSG00000230978 |
| Refseq | NR_024351 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | clear cell renal cell carcinoma |
| ICD-0-3 | C64.9 |
| Methods | qPCR etc. |
| Sample | kidney cancer and adjacent normal tissues,cell line (HK-2,786-O, OS-RC-2, ACHN, Caki-1) |
| Expression Pattern | up-regulated |
| Function Description | LNC00160 was significantly upregulated in ccRCC and high expression predicted poor prognosis;LINC00160 promotes proliferation, migration and invasion of RCC |
| Pubmed ID | 32315986 |
| Year | 2020 |
| Title | Overexpression of LINC00160 predicts poor outcome and promotes progression of clear cell renal cell carcinoma |
External Links
| Links for LINC00160 | GenBank HGNC NONCODE |
| Links for clear cell renal cell carcinoma | OMIM COSMIC |